Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest NxStage Medical Inc. Stories

2012-01-09 07:00:00

LAWRENCE, Mass., Jan. 9, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that its Medisystems in-center business and B. Braun Medical Inc. have agreed to extend their supply agreement under which Medisystems will supply B. Braun with its Streamline(®) blood tubing sets for use on the B. Braun Dialog(®) and Dialog(+® )hemodialysis systems, Medisystems MasterGuard(®) and Buttonhole(®) needles,...

2012-01-04 07:00:00

LAWRENCE, Mass., Jan. 4, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert Brown, Chief Financial Officer will present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on January 10th, at 4 p.m. PST. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) A webcast of the event will be made available at...

2011-11-22 07:29:00

LAWRENCE, Mass., Nov. 22, 2011 /PRNewswire/ -- Taking control of your dialysis and finding the information you need about home hemodialysis with the NxStage(®) System One((TM)) just got easier for end stage renal disease (ESRD) patients with the launch of the NxStage Find a Doctor directory. The on-line directory created by NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, makes it easier for patients to identify a nearby...

2011-11-11 07:00:00

LAWRENCE, Mass. and PHILADELPHIA, Nov. 11, 2011 /PRNewswire/ -- Booth # 407 at The American Society of Nephrology (ASN)'s Kidney Week 2011 -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that its Medisystems division has won a multi-year contract to supply the Vasc-Alert(TM) Access Surveillance Solution to Atlantic Dialysis Management Services centers. (Logo:...

2011-11-10 16:00:00

PALM SPRINGS, Calif., Nov. 10, 2011 /PRNewswire/ -- Five entrepreneurial leaders from Stella & Dot, Hara, NxStage Medical, Inc., and LinkedIn Corporation received the Ernst & Young Venture Capital Award of Excellence on Thursday, November 10, at Ernst & Young LLP's 2011 Strategic Growth Forum in Palm Springs, CA. Square 1 Bank co-sponsored the awards, which were announced during a luncheon ceremony. "Entrepreneurs are the key to innovation, economic growth, and job creation...

2011-11-10 09:17:00

LAWRENCE, Mass. and PHILADELPHIA, Nov. 10, 2011 /PRNewswire/ -- Booth # 407 at The American Society of Nephrology (ASN)'s Kidney Week 2011 -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, today announced that Ashita Tolwani, M.D., and William Fissell, M.D., recipients of a NxStage Research Grant, conducted a multi-center study evaluating the removal of Piperacillin during continuous renal replacement therapy (CRRT) in an acute setting for...

2011-11-10 07:00:00

LAWRENCE, Mass. and PHILADELPHIA, Nov. 10, 2011 /PRNewswire/ -- Booth # 407 at The American Society of Nephrology (ASN)'s Kidney Week 2011 -- NxStage(®) Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) study, showing patients experience a better overall quality of life while undergoing more...

2011-11-08 07:00:00

LAWRENCE, Mass., Nov. 8, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that former NxStage® System One(TM) patient David RUSH, 29, is celebrating the one-year anniversary of his successful kidney transplant during a special event on November 9, 2011. RUSH received the transplant following more than two years of more frequent home hemodialysis with the System One....

2011-11-04 07:30:00

LAWRENCE, Mass., Nov. 4, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, chief executive officer, will participate in the following schedule of investor conferences. Where possible, a webcast of the event will be made available at http://www.nxstage.com/ir.cfm at the time of each conference. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) UBS Access...

2011-11-03 06:12:00

LAWRENCE, Mass., Nov. 3, 2011 /PRNewswire/ -- Highlights: - Revenue Increases to $55.9 million, up 24% from Q3'10 - Home Market Increases to $27.2 million, up 22% from Q3'10 - Gross Margin Increases to 35%, up from 33% in Q3'10 NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported record financial results for the third quarter ended September 30, 2011, with total revenue well above the top end of its guidance range. (Logo:...